Barely Significant
← all excerpts

Optimal Timing for Postsurgical Adjuvant Therapy in Patients with Gastric Cancer: A Propensity Score Matching Study.

J Cancer · 2019 · PMC6360315 · PMID 30719127

1
hedged sentence
closest p
boldest claim

The sentences

After 1:1 matching that equalized the patients' baseline characteristics and sample size, we observed a significant benefit in RFS for patients who commenced AT within 8 weeks post-gastrectomy, whereas the OS benefit was just below the level of significance.

also in 26 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.